CAT-1004 regulatory update

FDA granted rare pediatric disease designation to CAT-1004 from Catabasis to treat Duchenne muscular dystrophy (DMD). CAT-1004 is in Phase I/II testing to treat DMD and has Fast Track and Orphan Drug ...